The market for multiplex biomarker imaging is anticipated to reach a valuation of USD 1,631.4 million by 2034, up from USD ...

Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, will present three ...

Considering Predictive Oncology’s ongoing process to evaluate strategic alternatives, the Company has elected not to host an investor conference call this quarter. Predictive plans to host a corporate ...

CHICAGO--GE HealthCare (Nasdaq: GEHC) has received FDA 510(k) clearance for its innovative SIGNA™ MAGNUS,i a 3.0T ...

We are encouraged by the potential benefit of ALTO-100, as demonstrated in the adjunctive population, and of our biomarker approach in patients with confirmed drug compliance, showing that enrichment ...

Begin your TipRanks Premium journey today. Compugen (CGEN) Company Description: Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker ...

Cardiologist Dr. Josiah Brown, specializing in minimally invasive therapies, is the newest team member at Alaska Heart & ...

Researchers conducted a cohort study to assess the predictive value of plasma MMP9 in antipsychotic treatment response among patients with schizophrenia.

However, the diagnostics segment accounted for the second-largest market share. Based on study type, the genomics market is segmented into functional genomics, biomarker discovery, pathway analysis, ...

Dubbed Xanamia, the double-blinded, placebo-controlled trial aims to enrol 220 patients with mild to moderate but progressive ...

GE HealthCare says the head-only design allows the system to deliver a gradient amplitude and slew rate far surpassing those ...

Professor Nancy Ip discusses her groundbreaking neuroscience research, focusing on neurotrophic factors and innovative ...